Genomes of Strongylocentrotus franciscanus and Lytechinus variegatus: are there any genomic explanations for the two order of magnitude difference in the lifespan of sea urchins?
Petr V. Sergiev , Artem A. Artemov , Egor B. Prokhortchouk , Olga A. Dontsova
Aging-us 8 ( 2) 260 -271
17
2016
Cell-intrinsic functions of the transcription factor Bhlhe40 in activated B cells and T follicular helper cells restrain the germinal center reaction and prevent lymphomagenesis
Busslinger M , Kreslavsky T , Kreslavsky T , Taneja R
bioRxiv
2021
Cell-intrinsic functions of the transcription factor Bhlhe40 in activated B cells and T follicular helper cells restrain the germinal center reaction and prevent lymphomagenesis
Busslinger M , Kreslavsky T , Kreslavsky T , Taneja R
bioRxiv
2021
CpG Traffic Lights: functional positions that are involved in regulation in humans
AV Lioznova , Abdullah M Khamis , AV Artemov , V Ramensky
WILEY
1
2017
Inactivation of VHL in kidney cancer cells affects genome methylation
AV Artemov , N Zhigalova , S Zhenilo , AM Mazur
FEBS JOURNAL 284 287 -287
2017
REGULATORY ROLE OF SINGLE CPG METHYLATION
A Khamis , AV Artemov , AV Lioznova , VB Bajic
THE TENTH 120 -120
2016
Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin
RR de Krijger , TK Olsen , N Akkuratova , ME Kastriti
A family study of early-onset Alzheimer's disease
Konstantin Skryabin , Sergey Rastorguev , Artem Nedoluzhko , Nikolay Chekanov
F1000Research 3
2012
System, Method and Software for Predicting Clinical Outcome of a Drug Treatment of Breast Cancer in a Patient
Denis Shepelin , Anton Buzdin , Ksenia Lezhnina , Alexander Zhavoronkov
2016
System, Method and Software for Predicting Drug Efficacy in a Patient
Denis Shepelin , Anton Buzdin , Ksenia Lezhnina , Alexander Zhavoronkov
2
2016
SYSTEM, METHOD AND SOFTWARE FOR ROBUST TRANSCRIPTOMIC DATA ANALYSIS
Anton Buzdin , Ksenia Lezhnina , Alexander Aliper , Nikolay Borisov
3
2017
Transcriptome sequencing revealed differences in the response of renal cancer cells to hypoxia and CoCl 2 treatment
Nadezhda Zhigalova , Artem Artemov , Alexander M. Mazur , Egor B. Prokhortchouk
F1000Research 4 1518 -1518
10
2015
A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation
Artem Artemov , Alexander Aliper , Michael Korzinkin , Ksenia Lezhnina
Oncotarget 6 ( 30) 29347 -29356
44
2015
Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data
Alexander Aliper , Sergey Plis , Artem Artemov , Alvaro Ulloa
Molecular Pharmaceutics 13 ( 7) 2524 -2530
407
2016
Design of efficient computational workflows for in silico drug repurposing
Quentin Vanhaelen , Polina Mamoshina , Alexander M. Aliper , Artem Artemov
Drug Discovery Today 22 ( 2) 210 -222
84
2017
1H NMR-based metabolic profiling of urinary tract infection: combining multiple statistical models and clinical data
Ekaterina Nevedomskaya , Tiziana Pacchiarotta , Artem Artemov , Axel Meissner
Metabolomics 8 ( 6) 1227 -1235
27
2012
Variation in genomic landscape of clear cell renal cell carcinoma across Europe
Ghislaine Scelo , Yasser Riazalhosseini , Liliana Greger , Louis Letourneau
Nature Communications 5 ( 1) 5135 -5135
111
2014
In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state.
Alexander Aliper , Aleksey V. Belikov , Andrew Garazha , Leslie Jellen
Aging (Albany NY) 8 ( 9) 2127 -2152
37
2016
A review of the biomedical innovations for healthy longevity
Alexey Moskalev , Vladimir Anisimov , Aleksander Aliper , Artem Artemov
Aging-us 9 ( 1) 7 -25
9
2017
Towards natural mimetics of metformin and rapamycin.
Alexander Aliper , Leslie Jellen , Franco Cortese , Artem Artemov
Aging 9 ( 11) 2245 -2268
79
2017